Scarica l'app Stockscreener
65.81
1.95%
-1.31
Pre-mercato:
65.56
-0.25
-0.38%
Precedente Chiudi:
$67.12
Aprire:
$67.12
Volume 24 ore:
722.67K
Relative Volume:
0.90
Capitalizzazione di mercato:
$3.60B
Reddito:
$1.39B
Utile/perdita netta:
$-242.49M
Rapporto P/E:
-14.70
EPS:
-4.4759
Flusso di cassa netto:
$173.29M
1 W Prestazione:
+1.90%
1M Prestazione:
+5.82%
6M Prestazione:
+21.65%
1 anno Prestazione:
+84.96%
Intervallo 1D:
$65.41
$68.00
Intervallo di 1 settimana:
$64.20
$68.04
Portata 52W:
$34.24
$71.92
Livanova Plc Stock (LIVN) Company Profile
Nome
Livanova Plc
Settore
Industria
Telefono
4402033250662
Indirizzo
20 EASTBOURNE TERRACE, LONDON
Compare LIVN vs ABT, SYK, MDT, BSX, EW
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
LIVN
Livanova Plc
|
65.81 | 3.67B | 1.39B | -242.49M | 173.29M | -4.4759 |
ABT
Abbott Laboratories
|
96.00 | 168.22B | 45.13B | 6.28B | 7.40B | 3.5895 |
SYK
Stryker Corp
|
338.34 | 131.49B | 25.12B | 3.25B | 4.28B | 8.3984 |
MDT
Medtronic Plc
|
85.00 | 110.66B | 35.48B | 4.64B | 5.41B | 3.582 |
BSX
Boston Scientific Corp
|
60.99 | 95.46B | 20.08B | 2.89B | 3.66B | 1.9391 |
EW
Edwards Lifesciences Corp
|
81.44 | 46.69B | 6.07B | 1.06B | 1.34B | 1.8063 |
Livanova Plc Stock (LIVN) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-12-19 | Iniziato | KeyBanc Capital Markets | Overweight |
| 2025-10-01 | Downgrade | Goldman | Buy → Neutral |
| 2025-05-20 | Aggiornamento | Wolfe Research | Peer Perform → Outperform |
| 2025-02-26 | Downgrade | Wolfe Research | Outperform → Peer Perform |
| 2024-10-04 | Iniziato | Goldman | Buy |
| 2024-09-17 | Aggiornamento | Robert W. Baird | Neutral → Outperform |
| 2024-03-20 | Reiterato | Needham | Buy |
| 2024-02-20 | Aggiornamento | Mizuho | Neutral → Buy |
| 2023-09-06 | Iniziato | HSBC Securities | Hold |
| 2023-07-19 | Iniziato | Robert W. Baird | Neutral |
| 2023-04-14 | Iniziato | Mizuho | Neutral |
| 2022-12-21 | Iniziato | Barclays | Equal Weight |
| 2022-04-06 | Iniziato | Wolfe Research | Outperform |
| 2022-02-24 | Aggiornamento | UBS | Neutral → Buy |
| 2021-12-03 | Iniziato | Goldman | Buy |
| 2021-08-20 | Reiterato | Needham | Buy |
| 2021-07-20 | Aggiornamento | Needham | Hold → Buy |
| 2021-03-03 | Downgrade | Berenberg | Buy → Hold |
| 2021-01-05 | Downgrade | Needham | Buy → Hold |
| 2020-09-02 | Iniziato | Robert W. Baird | Outperform |
| 2020-06-26 | Reiterato | Needham | Buy |
| 2019-10-30 | Reiterato | Needham | Buy |
| 2019-02-28 | Reiterato | Needham | Buy |
| 2018-11-28 | Iniziato | UBS | Neutral |
| 2018-08-02 | Reiterato | Needham | Buy |
| 2018-06-08 | Iniziato | Stifel | Buy |
| 2018-05-31 | Reiterato | Needham | Buy |
| 2018-02-28 | Reiterato | Needham | Buy |
Mostra tutto
Livanova Plc Borsa (LIVN) Ultime notizie
Annals of Internal Medicine Publishes 12-Month Results from LivaNova’s OSPREY Clinical Study for Obstructive Sleep Apnea - BioSpace
LivaNova PLC stock (US5356991077): Why does its medtech innovation edge matter more now? - AD HOC NEWS
Sleep apnea trial tracks a year of gains with LivaNova implant - Stock Titan
Tissue Heart Valves Market Key Companies AnalysisEdwards - openPR.com
LivaNova PLC (NASDAQ:LIVN) Receives Average Recommendation of "Moderate Buy" from Analysts - MarketBeat
In-Line Blood Monitoring Devices Market to Reach USD 0.42 - openPR.com
33,332 Shares in LivaNova PLC $LIVN Acquired by Tudor Investment Corp ET AL - MarketBeat
Behavioral Patterns of LIVN and Institutional Flows - Stock Traders Daily
Nasdaq Moves: Whats the fair value of LivaNova PLC stockMarket Performance Recap & Weekly Momentum Stock Picks - baoquankhu1.vn
Aberdeen Group plc Lowers Stock Holdings in LivaNova PLC $LIVN - MarketBeat
Market Catalysts: Is LivaNova PLC stock a falling knife or bargain buy2026 Trends & Stepwise Entry and Exit Trade Signals - baoquankhu1.vn
LivaNova PLC (LIVN) Stock Forecasts - Yahoo Finance
Allspring Global Investments Holdings LLC Reduces Stake in LivaNova PLC $LIVN - MarketBeat
Exchange Traded Concepts LLC Buys New Shares in LivaNova PLC $LIVN - MarketBeat
LivaNova PLC (LIVN) Stock forecasts - Yahoo Finance UK
LivaNova to present at JP Morgan Healthcare Conference in January - MSN
(LIVN) Movement Within Algorithmic Entry Frameworks - Stock Traders Daily
Aug Macro: Does LivaNova PLC stock benefit from AI growth2026 Earnings & Daily Volume Surge Signals - baoquankhu1.vn
Tudor Investment Corp ET AL Acquires Shares of 33,332 LivaNova PLC - National Today
Tudor Investment Corp ET AL Acquires Shares of 33,332 LivaNova PLC $LIVN - marketbeat.com
How FDA Approval of Aura6000 Sleep Apnea Therapy Will Impact LivaNova (LIVN) Investors - Sahm
MedTech's Edge: How AI and Remote Diagnostics Drive Scalable Value - Benzinga
Should FDA Approval of aura6000 Sleep Apnea Therapy Require Action From LivaNova (LIVN) Investors? - Yahoo Finance
LivaNova (LIVN) Announces FDA Approval of aura6000 System for Obstructive Sleep Apnea - Insider Monkey
LivaNova Broadens OSA Treatment Options With FDA Clearance for aura6000 System - Bitget
LivaNova Expands OSA Care With FDA-Approved aura6000 System - Yahoo Finance
LivaNova to Announce First-Quarter 2026 Results - Business Wire
LivaNova PLC stock faces analyst scrutiny amid mixed ratings and modest growth outlook in medical de - AD HOC NEWS
LivaNova gains FDA premarket approval for Aura6000 for sleep apnea - msn.com
LivaNova PLC (NASDAQ:LIVN) Receives Consensus Rating of "Moderate Buy" from Brokerages - MarketBeat
FDA Approves Hypoglossal Nerve Stimulation Device for OSA - Medical Dialogues
FDA Approves LivaNova’s aura6000 Neurostimulator for OSA - Sleep Review
LivaNova aura6000 Obstructive Sleep Apnea treatment granted FDA premarket approval - Med-Tech Insights
LivaNova eyes 2027 launch of neural sleep apnoea therapy after FDA approval - Medical Device Network
How (LIVN) Movements Inform Risk Allocation Models - Stock Traders Daily
LivaNova wins FDA approval for sleep apnea nerve device By Investing.com - in.investing.com
LIVN SEC FilingsLivanova Plc 10-K, 10-Q, 8-K Forms - Stock Titan
LivaNova granted premarket approval for aura6000 System by FDA - TipRanks
LivaNova wins FDA Approval for sleep apnea treatment device - Medical Economics
LivaNova (LIVN) Receives FDA Approval for Aura6000 Sleep Apnea S - GuruFocus
LivaNova Earns FDA Approval for Neurostim for Sleep Apnea - Medical Product Outsourcing
LivaNova wins FDA approval for sleep apnea nerve device - Investing.com
LivaNova gets FDA approval for sleep apnea device without collapse warning - StreetInsider
LivaNova Receives U.S. Food and Drug Administration Premarket Approval for aura6000 System to treat Moderate to Severe Obstructive Sleep Apnea - The Joplin Globe
LivaNova Shares Gain 2% After Strong Q3 Results and Upgraded Full-Year Outlook - MSN
LivaNova PLC announced that its Aura6000 system has received premarket approval from the U.S. Food and Drug Administration (FDA). The device is designed to treat moderate to severe obstructive sleep apnea. - Bitget
Patterns Watch: Is LivaNova PLC being accumulated by smart moneyMarket Performance Report & Momentum Based Trading Signals - baoquankhu1.vn
Short Interest in LivaNova PLC Rises By 18.0% - National Today
Short Interest in LivaNova PLC (NASDAQ:LIVN) Rises By 18.0% - MarketBeat
LIVN PE Ratio & Valuation, Is LIVN Overvalued - Intellectia AI
Livanova Plc Azioni (LIVN) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
0.74%
1.72%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):